Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pharmacyclics claims metallotexaphyrins and use in diagnosis and therapy

April 29, 2002

Faslodex approved in U.S. for tamoxifen-resistant breast cancer

April 29, 2002

EMEA accepts Thalomid MAA for review

April 29, 2002

Potent and selective CDK2 inhibitors with antitumor activity reported at ACS meeting

April 29, 2002

Pharmacia presents new integrin antagonists in patent literature

April 26, 2002

MediGene submits MAA in Germany for Eligard 22.5 mg

April 26, 2002

Bay-43-9006 discussed at AACR

April 26, 2002

European filing for Erbitux in colorectal and head and neck cancers delayed until 2003

April 25, 2002

European orphan drug designation for DTI-015 in malignant brain tumors

April 25, 2002

Genasense potentiates activity of anticancer agents, retains activity against resistant leukemia

April 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...